- Home
- HRMY vs FUBO Comparison
HRMY vs FUBO Comparison
Compare HRMY & FUBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HRMY
- FUBO
- Stock Information
- Founded
- HRMY 2017
- FUBO 2009
- Country
- HRMY United States
- FUBO United States
- Employees
- HRMY N/A
- FUBO N/A
- Industry
- HRMY Biotechnology: Pharmaceutical Preparations
- FUBO Broadcasting
- Sector
- HRMY Health Care
- FUBO Industrials
- Exchange
- HRMY Nasdaq
- FUBO Nasdaq
- Market Cap
- HRMY 1.5B
- FUBO 1.3B
- IPO Year
- HRMY 2020
- FUBO 2020
- Fundamental
- Price
- HRMY $31.40
- FUBO $3.85
- Analyst Decision
- HRMY Strong Buy
- FUBO Buy
- Analyst Count
- HRMY 9
- FUBO 4
- Target Price
- HRMY $50.44
- FUBO $5.35
- AVG Volume (30 Days)
- HRMY 912.0K
- FUBO 20.9M
- Earning Date
- HRMY 11-04-2025
- FUBO 11-03-2025
- Dividend Yield
- HRMY N/A
- FUBO N/A
- EPS Growth
- HRMY 50.44
- FUBO N/A
- EPS
- HRMY 3.17
- FUBO 0.35
- Revenue
- HRMY $825,944,000.00
- FUBO $1,616,726,000.00
- Revenue This Year
- HRMY $20.68
- FUBO N/A
- Revenue Next Year
- HRMY $15.93
- FUBO $6.48
- P/E Ratio
- HRMY $9.92
- FUBO $11.20
- Revenue Growth
- HRMY 21.13
- FUBO 1.70
- 52 Week Low
- HRMY $25.52
- FUBO $1.21
- 52 Week High
- HRMY $40.93
- FUBO $6.45
- Technical
- Relative Strength Index (RSI)
- HRMY 63.59
- FUBO 52.10
- Support Level
- HRMY $27.66
- FUBO $3.23
- Resistance Level
- HRMY $30.96
- FUBO $4.20
- Average True Range (ATR)
- HRMY 1.25
- FUBO 0.33
- MACD
- HRMY 0.54
- FUBO 0.04
- Stochastic Oscillator
- HRMY 92.89
- FUBO 53.22
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.
About FUBO fuboTV Inc.
FuboTV Inc is a sports-first, live TV streaming company offering subscribers access to tens of thousands of live sporting events annually as well as news and entertainment content. Its platform, FuboTV, allows customers to access content through streaming devices and on SmartTVs, mobile phones, tablets, and computers. It offers subscribers a live TV streaming service with the option to purchase incremental features available for purchase that include additional content or enhanced functionality suited to their preferences. The company has one operating segment, the streaming business. Geographically, the company generates a majority of its revenue from the United States and also has a presence in other markets.